täiskirje prindi

Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma

autor
Jueliger, Simone
Lyons, John
Cannito, Sara
Pata, Illar
Pata, Pille
Školnaja, Marianna
vastutusandmed
Simone Jueliger, John Lyons, Sara Cannito, Illar Pata, Pille Pata, Marianna Shkolnaya, Oriana Lo Re, Marion Peyrou, Francesc Villarroya, Valerio Pazienza, Francesca Rappa, Francesco Cappello, Mohammad Azab, Pietro Taverna, and Manlio Vinciguerra
allikas
Epigenetics
kirjastus/väljaandja
ajakirja aastakäik number kuu
vol. 11, 10
ilmumisaasta
leheküljed
p. 709-720 : ill
leitav
ISSN
1559-2294
märkused
Bibliogr.: 45 ref
Open Access
Open Access
teaduspublikatsioon
teaduspublikatsioon
keel
inglise
märksõna
võtmesõna
decitabine
DNA methylation
guadecitabine
hepatocellular carcinoma (HCC)
histone macroH2A1
steatohepatitis
Jueliger, S., Lyons, J., Cannito, S., Pata, I., Pata, P., Školnaja, M. et al. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma // Epigenetics (2016) vol. 11, 10, p. 709-720 : ill. https://doi.org/10.1080/15592294.2016.1214781